Adage Capital Partners
GNMK

Adage Capital Partners’s GenMark Diagnostics, Inc GNMK Stock Holding History

Adage Capital Partners’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-250,000
Closed -$3.65M – 1087
2020
Q4 		$3.65M Buy
+250,000
New +$3.31M 0.01% 717
2018
Q2 		– Sell
-300,000
Closed -$1.63M – 810
2018
Q1 		$1.63M Sell
300,000
-699,857
-70% -$3.48M ﹤0.01% 676
2017
Q4 		$4.17M Sell
999,857
-50,000
-5% -$301K 0.01% 638
2017
Q3 		$10.1M Sell
1,049,857
-350,000
-25% -$3.64M 0.02% 557
2017
Q2 		$16.6M Sell
1,399,857
-650,000
-32% -$8.31M 0.04% 454
2017
Q1 		$26.3M Sell
2,049,857
-200,000
-9% -$2.41M 0.07% 348
2016
Q4 		$27.5M Sell
2,249,857
-350,000
-13% -$4.16M 0.08% 315
2016
Q3 		$30.7M Sell
2,599,857
-100,000
-4% -$965K 0.08% 310
2016
Q2 		$23.5M Buy
2,699,857
+124,821
+5% +$856K 0.06% 336
2016
Q1 		$13.6M Buy
2,575,036
+350,000
+16% +$1.95M 0.04% 451
2015
Q4 		$17.3M Buy
2,225,036
+324,809
+17% +$2.5M 0.05% 412
2015
Q3 		$15M Sell
1,900,227
-118,930
-6% -$1.1M 0.04% 445
2015
Q2 		$18.3M Buy
2,019,157
+200,000
+11% +$2.02M 0.05% 428
2015
Q1 		$23.6M Sell
1,819,157
-6,070
-0.3% -$79.4K 0.06% 385
2014
Q4 		$24.8M Buy
1,825,227
+175,000
+11% +$1.96M 0.06% 359
2014
Q3 		$14.8M Hold
1,650,227
– – 0.04% 456
2014
Q2 		$22.3M Buy
1,650,227
+76,476
+5% +$798K 0.06% 371
2014
Q1 		$15.6M Sell
1,573,751
-43,196
-3% -$537K 0.04% 422
2013
Q4 		$21.5M Buy
1,616,947
+324,671
+25% +$3.94M 0.06% 380
2013
Q3 		$15.7M Buy
1,292,276
+691,248
+115% +$7.41M 0.05% 419
2013
Q2 		$6.22M Buy
+601,028
New +$8.29M 0.02% 570

Other funds holding GNMK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners's GNMK Position: Q1 2021 in Review

Adage Capital Partners sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 250,000 shares — an estimated $3.65M sold.

Adage Capital Partners first reported a position in GNMK in Q2 2013 and held it in 21 quarters. The position peaked at $30.7M in Q3 2016. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • Adage Capital Partners reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • Adage Capital Partners sold 250,000 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $3.65M.
  • Adage Capital Partners first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 21 quarters.
  • Adage Capital Partners's GenMark Diagnostics, Inc position peaked at $30.7M in Q3 2016.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.